Primary Care Edition

Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Drug News

Chemoradiotherapy Improves Survival for Elderly With NSCLC

May 22, 2012

For elderly patients with locally advanced non-small-cell lung cancer (NSCLC), treatment with radiotherapy plus carboplatin improves overall survival versus radiotherapy alone.

DDW: Estrogens Tied to Risk of Inflammatory Bowel Diseases

May 22, 2012

Hormone replacement therapy and oral contraceptives increase the risk of developing ulcerative colitis (UC) and Crohn's disease (CD), respectively.

Post-Stroke Inpatient Statins Improve Discharge Outcomes

May 22, 2012

Statin use during hospitalization for ischemic stroke significantly improves the likelihood of being discharged to home or institution.

Prenate Mini Vitamins Now Available

May 22, 2012

Avion Pharmaceuticals announced the launch of Prenate Mini, a once-daily easy-to-swallow prenatal vitamin capsule.

SAFETY ALERT: Risk of Cardiovascular Death with Zithromax

May 18, 2012

The FDA is notifying healthcare professionals of a new study reporting a small increase in cardiovascular death, and in the risk of death from any cause, in patients treated with a 5-day course of azithromycin (Zithromax; Pfizer) compared to persons treated with amoxicillin, ciprofloxacin, or no drug.

RECALL: Hydromorphone HCl Injection 1mg/mL Recall

May 14, 2012

Hospira has notified healthcare professionals of a recall of one lot of Hydromorphone HCl Injection 1mg/mL due to reports of a single Carpuject containing more than the 1mL labeled fill volume.

SAFETY ALERT: New Malignancy Risk with Revlimid

May 08, 2012

The FDA notified the public of an increased risk of second primary malignancies in patients with newly-diagnosed multiple myeloma who received Revlimid (lenalidomide capsules; Celgene).

RECALL: Franck's Compounding Triamcinolone Acetonide Recall

May 04, 2012

Franck's Compounding Pharmacy has recalled one additional lot of triamcinolone acetonide PF 80mg/mL.

DUTOPROL

5/21/2012

AstraZeneca Pharmaceuticals

Pharmacological Class: Cardioselective β₁-blocker + diuretic.

Active Ingredient(s): Metoprolol succinate extended-release, hydrochlorothiazide; 25/12.5mg, 50/12.5mg, 100/12.5mg; tablets.

Indication: Hypertension.

Daily Internal Medicine News

Conference News

Round-up

more >

Primary Care Courses on myCME.com

Type 2 Diabetes-A Chronic Care Model: Patient Specific Strategies for Enhanced Outcomes

1.00/ AMA PRA Category 1 Credit(s)^TM

Successfully Managing Persistent Pain in the Older Patient

1.00/ AMA PRA Category 1 Credit(s)^TM

Visit mycme.com

Primary Care Links

CME Webcast Series

This new, complimentary webcast series, presented by the Johns Hopkins University School of Medicine, is designed to help clinicians improve their ability to diagnose, manage, and treat cardiovascular and cardiometabolic disorders.

Click here for a full listing of activities.